dont agree, I guess we'll see in 5 years. No worries. The "point of care testing" products they have and dominant a large portion of that market will be standard of care long term. This line alone should do very well for them. Good luck. This is a stock like Labcorp or Quest Diagnostics that when you see it being used every day; are worth looking at as well..